I think this is the company (4d Molecular) in #4 that I must have been thinking over. Here is a link to a talk where they mention it briefly around the 4:15 mark
Interesting, thanks. Sounds like the speaker said the tech allows them to expose vector pool to human IVIG to develop vectors which evade pre-existing immunity in the population. I wonder how close to the clinic they are with this tech. Would be interesting to see them go public some day.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.